EpirubicinCyclophosphamideTaxoidsAntineoplastic Combined Chemotherapy ProtocolsDoxorubicinDrug Administration ScheduleBreast NeoplasmsFluorouracilAntibiotics, AntineoplasticPaclitaxelVincristineAntineoplastic Agents, AlkylatingTreatment OutcomePhosphoramide MustardsPrednisoneChemotherapy, AdjuvantMethotrexateDisease-Free SurvivalCisplatinGranulocyte Colony-Stimulating FactorCombined Modality TherapyAntineoplastic Agents, PhytogenicLeukopeniaEtoposideSurvival AnalysisDose-Response Relationship, DrugNeutropeniaInfusions, IntravenousAntineoplastic AgentsSurvival RateNeoadjuvant TherapyImmunosuppressive AgentsDeoxycytidineRemission InductionVinblastineThiotepaPulse Therapy, DrugAnthracyclinesRazoxaneIfosfamideNeoplasm MetastasisAlopeciaNeoplasm StagingBusulfanPrednisoloneMitoxantroneLymphoma, Non-HodgkinTime FactorsCarboplatinMaximum Tolerated DoseHematologic DiseasesDrug Therapy, CombinationAntibodies, Monoclonal, Murine-DerivedFollow-Up StudiesVomitingLung NeoplasmsNauseaBone Marrow TransplantationVidarabineHematopoietic Stem Cell TransplantationMethylprednisoloneDrug Resistance, NeoplasmTransplantation, AutologousAdenocarcinomaAdministration, OralInjections, IntravenousLymphatic MetastasisWhole-Body IrradiationCystitisReceptor, erbB-2Prospective StudiesDrug EvaluationAdministration, MetronomicNeoplasm Recurrence, LocalPrognosisNeoplasmsMastectomy, RadicalStomach NeoplasmsDisease ProgressionStomatitisAntibodies, MonoclonalCarmustineTransplantation ConditioningMelphalanBleomycinAntibodies, Monoclonal, HumanizedDrug SynergismImmunosuppressionHematopoietic Stem Cell MobilizationBiotransformationAzathioprineFeasibility StudiesLeukocyte CountWegener GranulomatosisLupus NephritisMesnaAmenorrheaBone NeoplasmsRecurrenceCarcinoma, Small Cell